Circulating tumor cells: The substrate of personalized medicine?

Frontiers in Oncology

Volumn 2 JUL, Issue , 2012, Pages

  Greene, Bryan T ^a,b   Hughes, Andrew D ^c   King, Michael R ^c  

^a BioCytics Inc   (United States)

^b PLLC   (United States)

^c Cornell University   (United States)

Author keywords

Circulating tumor cells; EpCAM; Leukapheresis; Leukopak; Selectins

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPITHELIAL CELL ADHESION MOLECULE; TRANSFORMING GROWTH FACTOR BETA1; VIMENTIN;

CANCER DIAGNOSIS; CELL GROWTH; CELL ISOLATION; CELL THERAPY; CIRCULATING TUMOR CELL; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LEUKAPHERESIS; METASTASIS; PERSONALIZED MEDICINE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; TREATMENT RESPONSE;

EID: 84872760025     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2012.00069     Document Type: Review

References (45)

1. Allard, W. J., Matera, J., Miller, M. C., Repollet, M., Connelly, M. C., Rao, C., Tibbe, A. G., Uhr, J. W., and Terstappen, L. W. (2004). Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin. Cancer Res. 10, 6897-6904.
2. Cho, E. H., Wendel, M., Luttgen, M., Yoshioka, C., Marrinucci, D., Lazar, D., Schram, E., Nieva, J., Bazhenova, L., Morgan, A., Ko, A. H., Korn, W. M., Kolatkar, A., Bethel, K., and Kuhn, P. (2012). Characterization of circulating tumor cell aggregates identified in patients with epithelial tumors. Phys. Biol. 9, 016001.
3. Eifler, R. L., Lind, J., Falkenhagen, D., Weber, V., Fischer, M. B., and Zeillinger, R. (2011). Enrichment of circulating tumor cells from a large blood volume using leukapheresis and elutriation: proof of concept. Cytometry B Clin. Cytom. 80, 100-111.
4. Galanzha, E. I., Kim, J. W., and Zharov, V. P. (2009a). Nanotechnology-based molecular photoacoustic and photothermal flow cytometry platform for in-vivo detection and killing of circulating cancer stem cells. J. Biophotonics 2, 725-735.
5. Galanzha, E. I., Shashkov, E. V., Spring, P. M., Suen, J. Y., and Zharov, V. P. (2009b). In vivo, noninvasive, label-free detection and eradication of circulating metastatic melanoma cells using two-color photoacoustic flow cytometry with a diode laser. Cancer Res. 69, 7926-7934.
6. Gleghorn, J. P., Pratt, E. D., Denning, D., Liu, H., Bander, N. H., Tagawa, S. T., Nanus, D. M., Giannakakou, P. A., and Kirby, B. J. (2010). Capture of circulating tumor cells from whole blood of prostate cancer patients using geometrically enhanced differential immunocapture (GEDI) and a prostate-specific antibody. Lab. Chip 10, 27-29.
7. Hayes, D. F., Walker, T. M., Singh, B., Vitetta, E. S., Uhr, J. W., Gross, S., Rao, C., Doyle, G. V., and Terstappen, L. W. (2002). Monitoring expression of HER-2 on circulating epithelial cells in patients with advanced breast cancer. Int. J. Oncol. 21, 1111-1117.
8. Hughes, A. D., and King, M. R. (2012). Nanobiotechnology for the capture and manipulation of circulating tumor cells. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 4, 291-309.
9. Hughes, A. D., Mattison, J., Western, L. T., Powderly, J. D., Greene, B. T., and King, M. R. (2012a). Microtube device for selectin-mediated capture of viable circulating tumor cells from blood. Clin. Chem. 58, 846-853.
10. Hughes, A. D., Mattison, J., Powderly, J. D., Greene, B. T., and King, M. R. (2012b). Rapid isolation of viable circulating tumor cells from patient blood samples. J. Vis. Exp. 64, e4248.
11. Kirby, B. J., Jodari, M., Loftus, M. S., Gakhar, G., Pratt, E. D., Chanel-Vos, C., Gleghorn, J. P., Santana, S. M., Liu, H., Smith, J. P., Navarro, V. N., Tagawa, S. T., Bander, N. H., Nanus, D. M., and Giannakakou, P. (2012). Functional characterization of circulating tumor cells with a prostate-cancer-specific microfluidic device. PLoS ONE 7, e35976. doi: 10.1371/journal.pone.0035976
12. Krebs, M. G., Hou, J. M., Sloane, R., Lancashire, L., Priest, L., Nonaka, D., Ward, T. H., Backen, A., Clack, G., Hughes, A., Ranson, M., Blackhall, F. H., and Dive, C. (2012). Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and-independent approaches. J. Thorac. Oncol. 7, 306-315.
13. Leversha, M. A., Han, J., Asgari, Z., Danila, D. C., Lin, O., Gonzalez-Espinoza, R., Anand, A., Lilja, H., Heller, G., Fleisher, M., and Scher, H. I. (2009). Fluorescence in situ hybridization analysis of circulating tumor cells in metastatic prostate cancer. Clin. Cancer Res. 15, 2091-2097.
14. Lin, H. K., Zheng, S. Y., Williams, A. J., Balic, M., Groshen, S., Scher, H. I., Fleisher, M., Stadler, W., Datar, R. H., Tai, Y. C., and Cote, R. J. (2010). Portable filter-based microdevice for detection and characterization of circulating tumor cells. Clin. Cancer Res. 16, 5011-5018.
15. Maheswaran, S., and Haber, D. A. (2010). Circulating tumor cells: a window into cancer biology and metastasis. Curr. Opin. Genet. Dev. 20, 96-99.
16. Maheswaran, S., Sequist, L. V., Nagrath, S., Ulkus, L., Brannigan, B., Collura, C. V., Inserra, E., Diederichs, S., Iafrate, A. J., Bell, D. W., Digumarthy, S., Muzikansky, A., Irimia, D., Settleman, J., Tompkins, R. G., Lynch, T. J., Toner, M., and Haber, D. A. (2008). Detection of mutations in EGFR in circulating lung-cancer cells. N. Engl. J. Med. 359, 366-377.
17. Marrinucci, D., Bethel, K., Kolatkar, A., Luttgen, M. S., Malchiodi, M., Baehring, F., Voigt, K., Lazar, D., Nieva, J., Bazhenova, L., Ko, A. H., Korn, W. M., Schram, E., Coward, M., Yang, X., Metzner, T., Lamy, R., Honnatti, M., Yoshioka, C., Kunken, J., Petrova, Y., Sok, D., Nelson, D., and Kuhn, P. (2012). Fluid biopsy in patients with metastatic prostate, pancreatic and breast cancers. Phys. Biol. 9, 016003.
18. Meng, S., Tripathy, D., Shete, S., Ashfaq, R., Haley, B., Perkins, S., Beitsch, P., Khan, A., Euhus, D., Osborne, C., Frenkel, E., Hoover, S., Leitch, M., Clifford, E., Vitetta, E., Morrison, L., Herlyn, D., Terstappen, L. W., Fleming, T., Fehm, T., Tucker, T., Lane, N., Wang, J., and Uhr, J. (2004). HER-2 gene amplification can be acquired as breast cancer progresses. Proc. Natl. Acad. Sci. U.S.A. 101, 9393-9398.
19. Mitchell, M. J., Chen, C. S., Ponmudi, V., Hughes, A. D., and King, M. R. (2012). E-selectin liposomal and nanotube-targeted delivery of doxorubicin to circulating tumor cells. J. Control Release 160, 609-617.
20. Mohamed, H., Murray, M., Turner, J. N., and Caggana, M. (2009). Isolation of tumor cells using size and deformation. J. Chromatogr. A 1216, 8289-8295.
21. Montgomery, M., and Cottler-Fox, M. (2007). Mobilization and collection of autologous hematopoietic progenitor/stem cells. Clin. Adv. Hematol. Oncol. 5, 127-136.
22. Muller, V., Stahmann, N., Riethdorf, S., Rau, T., Zabel, T., Goetz, A., Janicke, F., and Pantel, K. (2005). Circulating tumor cells in breast cancer: correlation to bone marrow micrometastases, heterogeneous response to systemic therapy and low proliferative activity. Clin. Cancer Res. 11, 3678-3685.
23. Nagrath, S., Sequist, L. V., Maheswaran, S., Bell, D. W., Irimia, D., Ulkus, L., Smith, M. R., Kwak, E. L., Digumarthy, S., Muzikansky, A., Ryan, P., Balis, U. J., Tompkins, R. G., Haber, D. A., and Toner, M. (2007). Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature 450, 1235-1239.
24. Nedosekin, D. A., Sarimollaoglu, M., Ye, J. H., Galanzha, E. I., and Zharov, V. P. (2011). In vivo ultra-fast photoacoustic flow cytometry of circulating human melanoma cells using near-infrared high-pulse rate lasers. Cytometry 79A, 825-833.
25. Pinzani, P., Salvadori, B., Simi, L., Bianchi, S., Distante, V., Cataliotti, L., Pazzagli, M., and Orlando, C. (2006). Isolation by size of epithelial tumor cells in peripheral blood of patients with breast cancer: correlation with real-time reverse transcriptase-polymerase chain reaction results and feasibility of molecular analysis by laser microdissection. Hum. Pathol. 37, 711-718.
26. Powell, A. A., Talasaz, A. H., Zhang, H., Coram, M. A., Reddy, A., Deng, G., Telli, M. L., Advani, R. H., Carlson, R. W., Mollick, J. A., Sheth, S., Kurian, A. W., Ford, J. M., Stockdale, F. E., Quake, S. R., Pease, R. F., Mindrinos, M. N., Bhanot, G., Dairkee, S. H., Davis, R. W., and Jeffrey, S. S. (2012). Single cell profiling of circulating tumor cells: transcriptional heterogeneity and diversity from breast cancer cell lines. PLoS ONE 7, e33788. doi: 10.1371/journal.pone.0033788
27. Punnoose, E. A., Atwal, S. K., Spoerke, J. M., Savage, H., Pandita, A., Yeh, R. F., Pirzkall, A., Fine, B. M., Amler, L. C., Chen, D. S., and Lackner, M. R. (2010). Molecular biomarker analyses using circulating tumor cells. PLoS ONE 5, e12517. doi: 10.1371/journal.pone.0012517
28. Rana, K., Liesveld, J. L., and King, M. R. (2009). Delivery of apoptotic signal to rolling cancer cells: a novel biomimetic technique using immobilized TRAIL and E-selectin. Biotechnol. Bioeng. 102, 1692-1702.
29. Restifo, N. P., Dudley, M. E., and Rosenberg, S. A. (2012). Adoptive immunotherapy for cancer: harnessing the T cell response. Nat. Rev. Immunol. 12, 269-281.
30. Riethdorf, S., Muller, V., Zhang, L., Rau, T., Loibl, S., Komor, M., Roller, M., Huober, J., Fehm, T., Schrader, I., Hilfrich, J., Holms, F., Tesch, H., Eidtmann, H., Untch, M., Von Minckwitz, G., and Pantel, K. (2010). Detection and HER2 expression of circulating tumor cells: prospective monitoring in breast cancer patients treated in the neoadjuvant GeparQuattro trial. Clin. Cancer Res. 16, 2634-2645.
31. Stoecklein, N. H., Niederacher, D., Topp, S. A., Fohrding, L. Z., Vay, C., Knoefel, W. T., Kasprowicz, N. S., Hepp, P. G., Mohrmann, S., Janni, W., Stratmann, A., Krahn, T., Honisch, E., Raba, K., and Fischer, J. C. (2012). Effect of leukapheresis on efficient CTC enrichment for comprehensive molecular characterization and clinical diagnostics. J. Clin. Oncol. 30(Suppl.), abstr. e21020.
32. Stott, S. L., Hsu, C. H., Tsukrov, D. I., Yu, M., Miyamoto, D. T., Waltman, B. A., Rothenberg, S. M., Shah, A. M., Smas, M. E., Korir, G. K., Floyd, F. P. Jr., Gilman, A. J., Lord, J. B., Winokur, D., Springer, S., Irimia, D., Nagrath, S., Sequist, L. V., Lee, R. J., Isselbacher, K. J., Maheswaran, S., Haber, D. A., and Toner, M. (2010a). Isolation of circulating tumor cells using a microvortex-generating herringbone-chip. Proc. Natl. Acad. Sci. U.S.A. 107, 18392-18397.
33. Stott, S. L., Lee, R. J., Nagrath, S., Yu, M., Miyamoto, D. T., Ulkus, L., Inserra, E. J., Ulman, M., Springer, S., Nakamura, Z., Moore, A. L., Tsukrov, D. I., Kempner, M. E., Dahl, D. M., Wu, C. L., Iafrate, A. J., Smith, M. R., Tompkins, R. G., Sequist, L. V., Toner, M., Haber, D. A., and Maheswaran, S. (2010b). Isolation and characterization of circulating tumor cells from patients with localized and metastatic prostate cancer. Sci. Transl. Med. 2, 25ra23.
34. Stratmann, A., Fischer, J. C., Niederacher, D., Raba, K., Schmitz, A., Kim, P. S., Singh, S., Stoecklein, N. H., and Krahn, T. (2012). A comprehensive comparision of circulating tumor cell capturing technologies by apheresis of cancer patients. J. Clin. Oncol. 30(Suppl.), abstr. e21017.
35. Talasaz, A. H., Powell, A. A., Huber, D. E., Berbee, J. G., Roh, K. H., Yu, W., Xiao, W., Davis, M. M., Pease, R. F., Mindrinos, M. N., Jeffrey, S. S., and Davis, R. W. (2009). Isolating highly enriched populations of circulating epithelial cells and other rare cells from blood using a magnetic sweeper device. Proc. Natl. Acad. Sci. U.S.A. 106, 3970-3975.
36. Tan, S. J., Yobas, L., Lee, G. Y., Ong, C. N., and Lim, C. T. (2009). Microdevice for the isolation and enumeration of cancer cells from blood. Biomed. Microdevices 11, 883-892.
37. Tinhofer, I., Hristozova, T., Stromberger, C., Keilhoiz, U., and Budach, V. (2012). Monitoring of circulating tumor cells and their expression of EGFR/phospho-EGFR during combined radiotherapy regimens in locally advanced squamous cell carcinoma of the head and neck. Int. J. Radiat. Oncol. Biol. Phys. [Epub ahead of print].
38. Vona, G., Sabile, A., Louha, M., Sitruk, V., Romana, S., Schutze, K., Capron, F., Franco, D., Pazzagli, M., Vekemans, M., Lacour, B., Brechot, C., and Paterlini-Brechot, P. (2000). Isolation by size of epithelial tumor cells-a new method for the immunomorphological and molecular characterization of circulating tumor cells. Am. J. Pathol. 156, 57-63.
39. Went, P. T., Lugli, A., Meier, S., Bundi, M., Mirlacher, M., Sauter, G., and Dirnhofer, S. (2004). Frequent EpCam protein expression in human carcinomas. Hum. Pathol. 35, 122-128.
40. Wesley, J., Whitmore, J., Trager, J., and Sheikh, N. (2012). An overview of sipuleucel-T: autologous cellular immunotherapy for prostate cancer. Hum. Vaccin. Immunother. 8, 520-527.
41. Wittekind, C., and Neid, M. (2005). Cancer invasion and metastasis. Oncology 69(Suppl. 1), 14-16.
42. Wulfing, P., Borchard, J., Buerger, H., Heidl, S., Zanker, K. S., Kiesel, L., and Brandt, B. (2006). HER2-positive circulating tumor cells indicate poor clinical outcome in stage I to III breast cancer patients. Clin. Cancer Res. 12, 1715-1720.
43. Zhang, Z., Han, L., Cao, L., Liang, X., Liu, Y., Liu, H., Du, J., Qu, Z., Zhu, C., Liu, S., Li, H., and Sun, W. (2008). Aggregation formation mediated anoikis resistance of BEL7402 hepatoma cells. Folia Histochem. Cytobiol. 46, 331-336.
44. Zharov, V. P., Galanzha, E. I., Shashkov, E. V., Kim, J. W., Khlebtsov, N. G., and Tuchin, V. V. (2007). Photoacoustic flow cytometry: principle and application for real-time detection of circulating single nanoparticles, pathogens, and contrast dyes in vivo. J. Biomed. Opt. 12, 051503.
45. Zheng, S., Lin, H., Liu, J. Q., Balic, M., Datar, R., Cote, R. J., and Tai, Y. C. (2007). Membrane microfilter device for selective capture, electrolysis and genomic analysis of human circulating tumor cells. J. Chromatogr. A 1162, 154-161.